The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer Sasha M. PejerreyDerek DustinSuzanne A. W. Fuqua Review 07 May 2018 Pages: 215 - 228
Adiposity Results in Metabolic and Inflammation Differences in Premenopausal and Postmenopausal Women Consistent with the Difference in Breast Cancer Risk H. ZhaoJ. WangS. E. Bulun Original Paper 15 March 2018 Pages: 229 - 239
The Impact of Hormonal Contraceptives on Breast Cancer Pathology Jesse A. DorchakSifat MariaPaula A. Witt-Enderby Original Paper 23 April 2018 Pages: 240 - 253
The Influence of Menopausal Hormone Therapy and Potential Lifestyle Interactions in Female Cancer Development—a Population-Based Prospective Study Marianne HolmAnja OlsenAnne Tjønneland Original Paper 14 June 2018 Pages: 254 - 264
The Flavonoid Apigenin Is a Progesterone Receptor Modulator with In Vivo Activity in the Uterus Matthew DeanJulia AustinJoanna E. Burdette Original Paper 07 May 2018 Pages: 265 - 277
Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome Zongping ChenJichun DengYuhong Yao Original Paper Open access 09 June 2018 Pages: 278 - 287
Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer Laurel GrantShantanu BanerjiMarshall W. Pitz Original Paper 18 June 2018 Pages: 288 - 294
